Eureka Therapeutics Achieves Regression of Metastatic Liver Cancer using ET140202 T-cell Therapy
–ONE COMPLETE RESPONSE (CR) OBSERVED IN PATIENT WITH METASTATIC LIVER CANCER –COMPANY EXPECTS TO INITIATE MULTICENTER PHASE 1 U.S. CLINICAL TRIALS IN 2019 EMERYVILLE, California,

